Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer

Journal of Clinical Oncology

Volumn 33, Issue 22, 2015, Pages 2424-2429

  Oktay, Kutluk ^a,b   Turan, Volkan ^a,b   Bedoschi, Giuliano ^a,b   Pacheco, Fernanda S ^a,b   Moy, Fred ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b Innovation Institute for Fertility Preservation and in Vitro Fertilization ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GONADOTROPIN; LETROZOLE; RECOMBINANT FOLLITROPIN; AROMATASE INHIBITOR; FOLLITROPIN; NITRILE; TRIAZOLE DERIVATIVE;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CRYOPRESERVATION; EMBRYO TRANSFER; FEMALE; FERTILITY PRESERVATION; FERTILIZATION IN VITRO; FOLLOW UP; GESTATIONAL AGE; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; NEWBORN; OUTCOME ASSESSMENT; PREGNANCY; PREGNANCY OUTCOME; PRIORITY JOURNAL; ANIMAL EMBRYO; BREAST NEOPLASMS; CANCER STAGING; EPIDEMIOLOGY; INFERTILITY, FEMALE; OVULATION INDUCTION; PATHOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA; TREATMENT OUTCOME; UNITED STATES;

ADULT; AROMATASE INHIBITORS; BREAST NEOPLASMS; CRYOPRESERVATION; EMBRYO, MAMMALIAN; FEMALE; FERTILITY PRESERVATION; FOLLICLE STIMULATING HORMONE; FOLLOW-UP STUDIES; HUMANS; INFERTILITY, FEMALE; NEOPLASM STAGING; NITRILES; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; TREATMENT OUTCOME; TRIAZOLES; UNITED STATES;

EID: 84940398612     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.59.3723     Document Type: Article

References (25)

1. Siegel R, Ma J, Zou Z, et al: Cancer statistics, 2014. CA Cancer J Clin 64:9-29, 2014
2. Anders CK, Johnson R, Litton J, et al: Breast cancer before age 40 years. Semin Oncol 36:237-249, 2009
3. Howlader N, Noone AM, Krapcho M, et al: (eds): SEER Cancer Statistics Review, 1975-2011. National Cancer Institute, Bethesda, MD. http://seer.cancer.gov/archive/csr/1975-2011/
4. Rodriguez-Wallberg KA, Oktay K: Fertility preservation medicine: Options for young adults and children with cancer. J Pediatr Hematol Oncol 32:390-396, 2010
5. Letourneau JM, Ebbel EE, Katz PP, et al: Pretreatment fertility counseling and fertility preservation improve quality of life in reproductive age women with cancer. Cancer 118:1710-1717, 2012
6. Rodriguez-Wallberg KA, Oktay K: Fertility preservation in women with breast cancer. Clin Obstet Gynecol 53:753-762, 2010
7. Nadji M, Gomez-Fernandez C, Ganjei-Azar P, et al: Immunohistochemistry of estrogen and progesterone receptors reconsidered: Experience with 5,993 breast cancers. Am J Clin Pathol 123:21-27, 2005
8. Sainsbury R: The development of endocrine therapy for women with breast cancer. Cancer Treat Rev 39:507-517, 2013
9. Davies C, Pan H, Godwin J, et al: Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet 381:805-816, 2013
10. Sonmezer M, Oktay K: Fertility preservation in young women undergoing breast cancer therapy. Oncologist 11:422-434, 2006
11. Loren AW, Mangu PB, Beck LN, et al: Fertility preservation for patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 31:2500-2510, 2013
12. Oktay K, Buyuk E, Libertella N, et al: Fertility preservation in breast cancer patients: A prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23:4347-4353, 2005
13. Azim AA, Costantini-Ferrando M, Oktay K: Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: A prospective controlled study. J Clin Oncol 26:2630-2635, 2008
14. Turan V, Bedoschi G, Moy F, et al: Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients. Fertil Steril 100:1681-1685, 2013
15. Reddy J, Turan V, Bedoschi G, et al: Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: An extended experience. J Assist Reprod Genet 31:927-932, 2014
16. Oktay K, Hourvitz A, Sahin G, et al: Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 91:3885-3890, 2006
17. Aflatoonian A, Oskouian H, Ahmadi S, et al: Can fresh embryo transfers be replaced by cryopreserved-thawed embryo transfers in assisted reproductive cycles? A randomized controlled trial. J Assist Reprod Genet 27:357-363, 2010
18. Trounson A, Mohr L: Human pregnancy following cryopreservation, thawing and transfer of an eight-cell embryo. Nature 305:707-709, 1983
19. Sonmezer M, Oktay K: Fertility preservation in female patients. Hum Reprod Update 10:251-266, 2004
20. Borini A, Cattoli M, Bulletti C, et al: Clinical efficiency of oocyte and embryo cryopreservation. Ann N Y Acad Sci 1127:49-58, 2008
21. Marrs RP, Greene J, Stone BA: Potential factors affecting embryo survival and clinical outcome with cryopreserved pronuclear human embryos. Am J Obstet Gynecol 190:1766-1771, 2004
22. Tiboni GM: Aromatase inhibitors and teratogenesis. Fertil Steril 81:1158-1159, 2004
23. Tulandi T, Martin J, Al-Fadhli R, et al: Congenital malformations among 911 newborns conceived after infertility treatment with letrozole or clomiphene citrate. Fertil Steril 85:1761-1765, 2006
24. Legro RS, Brzyski RG, Diamond MP, et al: Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med 371:119-129, 2014
25. Casper RF: Letrozole: Ovulation or superovulation? Fertil Steril 80:1335-1337, 2003